January 23, 2018
Haloperidol, Lorazepam, and Hospice in LTC─ What Hospices Need to Know About the Psychotropic Medications and the LTC Mega Rule
Haloperidol, Lorazepam, and Hospice in LTC─
What Hospices Need to Know About
the Psychotropic Medications and the LTC Mega Rule
Implementation of phase 2 of the nursing facility Mega Rule began on November 28, 2017. Within this portion of the rule, there are significant implications for hospices who partner with nursing facilities as it relates to medications for end of life care. Join Bridget McCrate Protus and Stephanie DeWees as they navigate the Mega Rule for hospice providers.
January 23, 2018
11:00 am - 12:00 pm
Who will benefit from this webinar?
Hospice Administrators, Nurse Managers, Staff Nurses, Pharmacists
Bridget McCrate Protus, Pharm D, MLIS, BCGP, CDP
Director of Drug Information
Stephanie DeWees, LPN, LNHA, BS Health Administration
Quality & Regulatory Specialist - Long Term Care
$25 - LeadingAge Ohio Member
$75 - Non-member
Two Easy Ways to Register
Online Registration: Click here to register online.
Register by Mail: Print the registration form and mail to:
2233 North Bank Drive
Columbus, OH 43220
Your registration will be complete upon receipt of this form and payment. All registrants will receive an email confirmation. If you do not receive a confirmation, please contact Corey Markham at (614) 545-9015. or firstname.lastname@example.org.
Substitution and Cancellation Policy: Substitutions, in writing, are welcome at no additional cost. Cancellations received by two calendar weeks prior to event date will be fully refunded. Cancellations received between 7 and 13 days prior to the event date will be refunded minus a $10 processing fee. No refunds will be issued 6 or fewer days prior to the event date.
Continuing Education Information
This event will provide 1.0 clock hours. Criteria for completion: Attendance at entire event and submission of completed evaluation form. The planning committee & presenter have declared no conflict of interest. Presenter(s) agrees to present fairly and without bias.
LeadingAge Ohio is an approved provider of continuing nursing education by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91) (OH-248/4-01-18)
LeadingAge Ohio is an approved provider by the Board of Executives of Long Term Services and Supports, (LAO09-SS-18).